Pediatr. praxi. 2024;25(3):166-169 | DOI: 10.36290/ped.2024.034

Therapeutic options for arterial hypertension in children

MUC. Jiří Kodeš, MUDr. Petra Matalová, Ph.D.
Ústav farmakologie LF UP a FN Olomouc

Arterial hypertension is a chronic disease with constantly increasing prevalence in both adult and paediatric patients. The goal of treatment is to normalise the blood pressure values and to prevent or regress organ damage. In primary hypertension treatment, regime measures are the first-line approach. These include increased physical activity, dietary adjustments and weight reduction. In cases of insufficient efficacy, pharmacotherapy is introduced after 6-12 months, initially as monotherapy, eventually in combinations later. Five groups of antihypertensive drugs can be administered in children - angiotensin-converting enzyme inhibitors, AT1 receptor antagonists for angiotensin II, calcium channel blockers, thiazide diuretics and beta-blockers. In children with secondary hypertension, the treatment of the primary disease is predominant and is supported by both non-pharmacological and pharmacological therapeutic options.

Keywords: arterial hypertension, children, treatment, regime measures, pharmacotherapy.

Accepted: June 12, 2024; Published: June 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kodeš J, Matalová P. Therapeutic options for arterial hypertension in children. Pediatr. praxi. 2024;25(3):166-169. doi: 10.36290/ped.2024.034.
Download citation

References

  1. Bassareo PP, Calcaterra G, Sabatino J, et al. Primary and secondary paediatric hypertension. J Cardiovasc Med. 2023; 24(1):77-85. Go to original source... Go to PubMed...
  2. Seeman T. Hypertenze u dětí a dospívajících. Pediatr. praxi. 2012;13(4):275-277.
  3. Seeman T. Hypertenze u dětí - výjimka, nebo stoupající trend?. Pediatr. praxi. 2022;23(3):192-195. Go to original source...
  4. Seeman T. Hypertenze v dětství a dospívání. In: Widimský J et al. Hypertenze. Praha 4: Maxdorf s. r. o.; 2019:434-455.
  5. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. Journal of Hypertension. 2016;(34)10:1887-1920. Go to original source... Go to PubMed...
  6. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3). Go to original source... Go to PubMed...
  7. Kodeš J, Matalová P. Arteriální hypertenze u dětských pacientů. Pediatr. praxi. 2023;24(6):380-382. Go to original source...
  8. Katrnošková S, Gregorová J, Peychl I. Dlouhodobá farmakoterapie primární hypertenze u dětí. Pediatr. praxi 2021;22(6):393-398. Go to original source...
  9. Šamánek M, Urbanová Z, Reich O, et al. Doporučení pro diagnostiku a léčbu hypertenze v dětství a dospívání. Cor Vasa. 2009;51(3):227-235. Go to original source...
  10. Virdis A, Giannarelli C, Fritsch Neves M, et al. Cigarette Smoking and Hypertension. Current Pharmaceutical Design. 2010;16(23):2518-2525. Go to original source... Go to PubMed...
  11. Langerová P, Vrtal J, Fürstová J. Výskyt off-label a unlicensed preskripce u dětí. Klin Farmakol Farm. 2012;26(4):161-165.
  12. Mediately [Internet]. Ljubljana: MODRA JAGODA, d.o.o; 2017. [cited 2023 Nov 15]. Available from: https://mediately.com/cz.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.